Vivo Bio Tech Adjusts Evaluation Score Amid Mixed Financial Performance and Profit Growth

May 13 2025 08:14 AM IST
share
Share Via
Vivo Bio Tech has recently adjusted its evaluation score, reflecting changes in its market outlook. The company has faced a decline in net sales over five years and shows weak debt management. However, it reported an 80.8% year-on-year profit increase, indicating some operational resilience amidst challenges.
Vivo Bio Tech, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an adjustment in its evaluation score. This revision reflects a shift in the technical landscape surrounding the stock, indicating a transition from a bearish outlook to a mildly bearish stance.

Key financial metrics reveal a mixed performance. Over the past five years, the company has experienced a compound annual growth rate (CAGR) decline of -3.37% in net sales, which raises concerns about its long-term fundamental strength. Additionally, the company's ability to manage its debt appears weak, as evidenced by a low EBIT to interest ratio of 1.97. Despite these challenges, Vivo Bio Tech reported a notable increase in profits, with a year-on-year rise of 80.8%, highlighting some operational resilience.

The stock's technical indicators, including MACD and KST, suggest a bearish sentiment, while the return on equity stands at an average of 7.95%, indicating limited profitability relative to shareholders' funds. Overall, the adjustment in evaluation reflects the complexities of Vivo Bio Tech's current market position and performance indicators.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News